| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000178440.5 |
Pazopanib |
Bladder urothelial carcinoma |
0.027215542 |
Resistant |
| ENSG00000178440.5 |
Pazopanib |
Sarcoma |
0.049498409 |
Resistant |
| ENSG00000178440.5 |
Pazopanib |
Kidney renal clear cell carcinoma |
0.04812214 |
Sensitive |
| ENSG00000178440.5 |
Pazopanib |
Skin cutaneous melanoma |
0.029250256 |
Sensitive |
